PDS Biotechnology (FRA:EU6) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EU6 PDS Biotechnology Corp FRA:EU6
26 GF Score
Price €0.70
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


PDS Biotechnology  (FRA:EU6) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


PDS Biotechnology Cyclically Adjusted PB Ratio Related Terms


PDS Biotechnology Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for PDS Biotechnology's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PDS Biotechnology Cyclically Adjusted PB Ratio Chart

PDS Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.68 0.24 0.07 0.06

PDS Biotechnology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.04 0.04 0.03 0.06

FRA:EU6 vs KPRX, ASBP, SNTI: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, PDS Biotechnology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PDS Biotechnology Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's Cyclically Adjusted PB Ratio falls into.


FRA:EU6
26GF Score
PDS Biotechnology Corp FRA:EU6
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PDS Biotechnology Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

PDS Biotechnology's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, PDS Biotechnology's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.056/333.9520*333.9520
=-0.056

Current CPI (Jun. 2026) = 333.9520.

PDS Biotechnology Quarterly Data

Book Value per Share CPI Adj_Book
201609 60.014 241.428 83.014
201612 58.539 241.432 80.972
201703 50.692 243.801 69.437
201706 47.931 244.955 65.345
201709 40.927 246.819 55.375
201712 33.653 246.524 45.588
201803 23.045 249.554 30.839
201806 18.232 251.989 24.162
201809 17.030 252.439 22.529
201812 -10.579 251.233 -14.062
201903 4.209 254.202 5.529
201906 3.495 256.143 4.557
201909 2.708 256.759 3.522
201912 1.973 256.974 2.564
202003 1.181 258.115 1.528
202006 0.986 257.797 1.277
202009 1.188 260.280 1.524
202012 0.996 260.474 1.277
202103 0.931 264.877 1.174
202106 2.166 271.696 2.662
202109 2.059 274.310 2.507
202112 1.954 278.802 2.341
202203 1.765 287.504 2.050
202206 1.728 296.311 1.948
202209 1.688 296.808 1.899
202212 1.367 296.797 1.538
202303 1.229 301.836 1.360
202306 0.963 305.109 1.054
202309 0.746 307.789 0.809
202312 0.715 306.746 0.778
202403 0.939 312.332 1.004
202406 0.784 314.175 0.833
202409 0.535 315.301 0.567
202412 0.483 315.605 0.511
202503 0.456 319.799 0.476
202506 0.292 322.561 0.302
202509 0.169 324.800 0.174
202512 0.144 324.054 0.148
202603 0.061 330.213 0.062
202606 -0.056 333.952 -0.056

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
26GF Score

Get the complete analysis for FRA:EU6

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.70
Price